Références
Coppo P, Bussel A, Charrier S, et al (2003) High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome. Medicine (Baltimore) 82(1):27–38
George JN (2010) How I treat patients with thrombotic thrombocytopenic purpura. Blood
Michael M, Elliott EJ, Craig JC, et al (2009) Interventions for hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials. Am J Kidney Dis 53(2):259–272
George JN (2008) Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder. Bone Marrow Transplant 41(11):917–918
Dundas S, Murphy J, Soutar RL, et al (1999) Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak. Lancet 354(9187):1327–1330
Noris M, Remuzzi G (2009) Atypical hemolytic-uremic syndrome. N Engl J Med 361(17):1676–1687
Rock GA, Shumak KH, Buskard NA, et al (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 325(6):393–397
Henon P (1991) Treatment of thrombotic thrombopenic purpura: results of a multicenter randomized clinical study. Presse Med 20(36):1761–1767
Wallis JP (2007) Transfusion-related acute lung injury (TRALI): presentation, epidemiology and treatment. Intensive Care Med 33(Suppl 1):S12–S16
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Duveau, A., Lerolle, N. Microangiopathie thrombotique en réanimation — Prise en charge initiale chez l'adulte. Réanimation 20 (Suppl 2), 332–337 (2011). https://doi.org/10.1007/s13546-010-0111-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13546-010-0111-4